Search results for "controlled release"

showing 5 items of 135 documents

Microencapsulation of Enteric Bacteriophages in a pH-Responsive Solid Oral Dosage Formulation Using a Scalable Membrane Emulsification Process

2019

A scalable low-shear membrane emulsification process was used to produce microencapsulated Escherichia coli-phages in a solid oral dosage form. Uniform pH-responsive composite microparticles (mean size ~100 &micro

maha-suolitulehduslcsh:RS1-441Pharmaceutical Sciencebacteriophage therapy<i>E. coli</i>ArticleDosage formbakteriofagitRSlaw.inventionlääkesuunnittelulcsh:Pharmacy and materia medica03 medical and health sciencesConfocal microscopylawEscherichiaenterobakteeritMembrane emulsification030304 developmental biology0303 health sciencesChromatographybiologykalvot (tekniikka)030306 microbiologyChemistryenteric infectionsE. colibiology.organism_classificationControlled releaseIn vitroQR3. Good healthfagiterapiamikrorakenteetpH-triggered releaseCell cultureGastric acidmicroencapsulationcontrolled releaseEudragit S100Pharmaceutics
researchProduct

Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment

2017

Curcumin is a natural molecule with proved anticancer efficacy on several human cancer cell lines. However, its clinical application has been limited due to its poor bioavailability. Nanocarrier-based drug delivery approaches could make curcumin dispersible in aqueous media, thus overtaking the limits of its low solubility. The aim of this study was to increase the bioavailability and the antitumoral activity of curcumin, by entrapping it into nanostructured lipid carriers (NLCs). For this purpose here we describe the preparation and characterization of three kinds of curcumin-loaded NLCs. The nanosystems allowed the achievement of a controlled release of curcumin, the amounts of curcumin r…

nanostructured lipid carriers curcumin drug release cancer epithelial ovarian cellsCurcuminNanoparticleAdministration Oral02 engineering and technologyPharmacologynanostructured lipid carrier03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsNanoparticleSettore BIO/10 - BiochimicamedicineHumanscancerParticle SizeDrug Carrierdrug releaseCell ProliferationOvarian NeoplasmsDrug CarriersOvarian NeoplasmChemistry (all)General ChemistryLipid021001 nanoscience & nanotechnologyBiocompatible materialmedicine.diseaseControlled releaseLipidsBioavailabilitychemistryAgricultural and Biological Sciences (all)Settore CHIM/09 - Farmaceutico Tecnologico Applicativo030220 oncology & carcinogenesisDrug deliveryCurcuminNanoparticlesFemaleNanocarriers0210 nano-technologyGeneral Agricultural and Biological SciencesOvarian cancerDrug Delivery Systemepithelial ovarian cellHuman
researchProduct

SMART NANOSPONGE-BASED SYSTEMS FOR ADVANCED APPLICATIONS

2023

rosmarinic acidpolymerrelaxometrysmart materialSettore CHIM/06 - Chimica Organicaquercetinphotocatalysifolic acidcontrolled release dyecyclodextrinheuristic analysiadsorptionpH-tunabilitycalixarenenanomaterialnanospongeFFC-NMR
researchProduct

Dual Enzyme-Triggered Controlled Release on Capped Nanometric Silica Mesoporous Supports

2012

The development of nanoscopic hybrid materials equipped with “molecular gates” showing the ability of releasing target entrapped guests upon the application of an external trigger has attracted great attention and has been extensively explored during recent years.1 These nanodevices are composed of two subunits, namely, a suitable support and certain capping entities grafted on the surface of the scaffolding.2 The support is used as a suitable reservoir in which certain chemicals can be stored whereas the molecules grafted in the outer surface act as a “gate” and can control the release of the entrapped molecules at will. Both components are carefully selected and arranged in order to achie…

ureaseINGENIERIA DE LA CONSTRUCCIONChemistryQUIMICA INORGANICANanoparticleNanotechnologyGeneral Chemistrymesoporous materialsControlled releaseUreaseCommunicationsMesoporous materialsQUIMICA ORGANICADrug deliveryDrug deliverydrug deliveryMoleculeControlled releaseNanoparticlesnanoparticlesMesoporous materialHybrid materialcontrolled releaseNanoscopic scale
researchProduct

Biodegradable Metal-Organic Framework-Based Microrobots (MOFBOTs).

2020

Microrobots and metal–organic frameworks (MOFs) have been identified as promising carriers for drug delivery applications. While clinical applications of microrobots are limited by their low drug loading efficiencies and the poor degradability of the materials used for their fabrication, MOFs lack motility and targeted drug delivery capabilities. The combination of these two fields marks the beginning of a new era; MOF‐based small‐scale robots (MOFBOTs) for biomedical applications. Yet, biodegradability is a major hurdle in the field of micro‐ and nanoswimmers including small‐scale robots. Here, a highly integrated MOFBOT that is able to realize magnetic locomotion, drug delivery, and selec…

zeolitic imidazolate frameworksMaterials scienceBiomedical EngineeringPharmaceutical ScienceNanotechnology02 engineering and technology010402 general chemistrybiodegradation01 natural sciencesBiomaterialsmetal–organic frameworksDrug Delivery SystemsNeoplasmsHumansMetal-Organic FrameworksBiodegradable metal021001 nanoscience & nanotechnologyControlled release0104 chemical sciencesMagnetic FieldsTargeted drug deliverySelective degradationDoxorubicindrug deliveryDrug deliverybiodegradation; drug delivery; metal–organic frameworks; microrobots; zeolitic imidazolate frameworksChemotherapeutic drugs0210 nano-technologymicrorobotsAdvanced healthcare materials
researchProduct